Villeneuve-d'Ascq, France · Founded 2020 · Privately Held (backing)
Operator of a biotechnology platform intended to treat resistant tumors using proprietary photosensitizing molecules paired with advanced laser light technologies. Hemerion Therapeutics is based in Villeneuve-d'Ascq, France and was founded in 2020. Its last reported valuation was $26.2 million in May 2025. It has raised $14.2 million.
Last reported valuation
$26.2M
Oct 2026
Priced at
—
Total raised
$14.2M
Last round
—
Cap table — not yet on record
Hemerion Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hemerion Therapeutics with a free account
·Watch Hemerion Therapeutics: the Monday email on marks, rounds and moves
